GUCY2C

Chr 12ADAR

guanylate cyclase 2C

Also known as: DIAR6, GC-C, GCC, GUC2C, HSER, MECIL, MUCIL, STAR

This protein is a transmembrane guanylyl cyclase that synthesizes cyclic GMP from GTP and serves as a receptor for endogenous peptides guanylin and uroguanylin. Mutations cause familial diarrhea with autosomal dominant inheritance and meconium ileus with autosomal recessive inheritance. The gene shows tolerance to loss-of-function variants (LOEUF 1.079), suggesting different mutation types may underlie the distinct clinical presentations and inheritance patterns.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Diarrhea 6MIM #614616
AD
Meconium ileusMIM #614665
AR
1
Active trials
11
Pubs (1 yr)
13
P/LP submissions
23%
P/LP missense
1.08
LOEUF
Multiple*
Mechanism· G2P
Clinical SummaryGUCY2C
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 357 VUS of 600 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — GUCY2C
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.08LOEUF
pLI 0.000
Z-score 1.04
OE 0.85 (0.681.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.25Z-score
OE missense 0.85 (0.790.92)
500 obs / 585.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.85 (0.681.08)
00.351.4
Missense OE0.85 (0.790.92)
00.61.4
Synonymous OE0.87
01.21.6
LoF obs/exp: 51 / 59.7Missense obs/exp: 500 / 585.1Syn Z: 1.49
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGUCY2C-related familial diarrheaGOFAD
definitiveGUCY2C-related meconium ileusLOFAR
DN
0.6259th %ile
GOF
0.72top 25%
LOF
0.3648th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFWe aimed to characterize the impact of an activating GUCY2C mutation on the gut microbiota in patients with FGDS controlling for Crohn's disease status and to determine whether changes share features with those observed in unrelated patients with IBD.PMID:28902124

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

600 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic3
VUS357
Likely Benign208
Benign5
Conflicting4
10
Pathogenic
3
Likely Pathogenic
357
VUS
208
Likely Benign
5
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
9
0
10
Likely Pathogenic
1
2
0
0
3
VUS
22
289
39
7
357
Likely Benign
0
1
105
102
208
Benign
0
0
5
0
5
Conflicting
4
Total23293158109587

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GUCY2C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗